person reading

About Revance Therapeutics Inc - Company Information, Overview, History and Profile

What does Revance Therapeutics Inc do?

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Revance Therapeutics Inc Management structure

All Gross Remunerations are in USD
Mr. Dustin S Sjuts
President
-
2024
Gross Remuneration
Year

Revance Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Dr. Vlad Coric, M.D.
Independent Director
421.49 K
2023
Gross Remuneration
Year
Mr. Angus Charles Russell
Chairman of the Board
346.03 K
2023
Gross Remuneration
Year
Ms. Jill Beraud
Independent Director
317.53 K
2023
Gross Remuneration
Year
Mr. Christian W. Nolet, C.P.A.
Independent Director
315.03 K
2023
Gross Remuneration
Year
Mr. Julian S. Gangolli
Independent Director
305.03 K
2023
Gross Remuneration
Year
Ms. Carey O’Connor Kolaja
Independent Director
304.18 K
2023
Gross Remuneration
Year